Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Oct 15, 2026; 18(10): 121843
Published online Oct 15, 2026. doi: 10.4251/wjgo.121843
Published online Oct 15, 2026. doi: 10.4251/wjgo.121843
Figure 7
Levels of CD3+ T cells and CD20+ B cells in the same esophageal squamous cell carcinoma patient’s tumor tissues.
- Citation: Ma LL, Hao MF, Chen MX, Lu YJ, Su JT, Tong S, Wang JW, Li X, Wei LY, Wang WW, Duan XX, Wang JS. CHMP2A as a potential prognostic biomarker for esophageal squamous cell carcinoma promotes tumor angiogenesis and cancer progression. World J Gastrointest Oncol 2026; 18(10): 121843
- URL: https://www.wjgnet.com/1948-5204/full/v18/i10/121843.htm
- DOI: https://dx.doi.org/10.4251/wjgo.121843